College Station, Texas
Caliber Biotherapeutics opened a 145,000-sf biopharmaceutical production plant in April of 2011 in College Station, Texas. The facility will support the manufacturing of vaccines and protein-based drugs using tobacco plants instead of conventional egg-based methodologies. The project features modular cleanroom pods for purification and laboratory equipment. Caliber Therapeutics represents a research partnership of Texas A&M University and G-Con LLC.
